Involvement of Inducible Nitric Oxide Synthase and Receptor for Advanced Glycation End Products in Periapical Granulomas

Journal of Endodontics

Volumn 33, Issue 2, 2007, Pages 137-141

  Hama, Shinji ^a   Takeichi, Osamu ^b   Saito, Ichiro ^c   Ito, Koichi ^d  

^a NIHON UNIVERSITY   (Japan)

^b Dental Research Center   (Japan)

^c TSURUMI UNIVERSITY   (Japan)

^d Dental Research Center

Author keywords

Immunohistochemistry; inducible nitric oxide synthase; periapical granulomas; periapical periodontitis; receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CHRONIC DISEASE; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; TOOTH PERIAPICAL DISEASE;

ADULT; AGED; ANALYSIS OF VARIANCE; CHRONIC DISEASE; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOCYTES; MACROPHAGES; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; PERIAPICAL GRANULOMA; RECEPTORS, IMMUNOLOGIC; STATISTICS, NONPARAMETRIC;

EID: 33846401512     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2006.11.011     Document Type: Article

References (30)

1. Chartrain N.A., Geller D.A., Koty P.P., et al. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 269 (1994) 6765-6772
2. Moncada S., and Higgs A. The L-arginine nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
3. Tunbridge A.J., Stevanin T.M., Lee M., et al. Inhibition of macrophage apoptosis by Neisseria meningitidis requires nitric oxide detoxification mechanisms. Infect Immun 74 (2006) 729-733
4. Hagen T., Taylor C.T., Lam F., and Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1α. Science 302 (2003) 1975-1978
5. Nisoli E., Clementi E., Paolucci C., et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299 (2003) 896-899
6. Karabucak B., Walsch H., Jou Y.T., Simchon S., and Kim S. The role of endothelial nitric oxide in the Substance P induced vasodilation in bovine dental pulp. J Endod 31 (2005) 733-736
7. Hofmann M.A., Drury S., Fu C., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97 (1999) 889-901
8. Schmidt A.M., and Stern D. RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends Endocrinol Metab 11 (2000) 368-375
9. Tanaka N., Yonekura H., Yamagishi S., Fujimori H., Yamamoto Y., and Yamamoto H. The receptor for advanced glycation end products is induced by the glycation end products themselves and tumor necrosis factor alpha through nuclear factor-kappa B, and by 17beta- estradiol through sp-1 in human vascular endothelial cells. J Biol Chem 275 (2000) 25781-25790
10. Feng L., Matsumoto C., Schwartz A., Schmidt A.M., Stern D.M., and Pile-Spellman J. Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis. Diabetes Care 28 (2005) 379-384
11. Hofmann M.A., Drury S., Hudson B.I., et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 3 (2002) 123-135
12. Katz J., Stavropoulos F., Bhattacharyya I., Stewart C., Perez F.M., and Caudle R.M. Receptor of advanced glycation end products (RAGE) expression in the minor salivary glands of patients with Sjögren's syndrome: a preliminary study. Scand J Rheumatol 33 (2004) 174-178
13. Nair P.N. New perspectives on radicular cysts: do they heal?. Int Endod J 31 (1998) 155-160
14. Van't Hof R.J., and Ralston S.H. Nitric oxide and bone. Immunology 103 (2001) 255-261
15. Takeichi O., Saito I., Hayashi M., Tsurumachi T., and Saito T. Production of human-inducible nitric oxide synthase in radicular cysts. J Endod 24 (1998) 157-160
16. Roodman G.D. Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 53 (1993) S94-S98
17. Le J., and Vilcek J. Biology of disease. Tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest 56 (1987) 234-248
18. Takeichi O., Saito I., Okamoto Y., Tsurumachi T., and Saito T. Cytokine regulation on the synthesis of nitric oxide in vivo by chronically infected human polymorphonuclear leukocytes. Immunology 93 (1998) 275-280
19. Takeichi O., Hayashi M., Tsurumachi T., et al. Inducible nitric oxide synthase activity by interferon-γ-producing cells in human radicular cysts. Int Endod J 32 (1999) 124-130
20. Stern D.M., Yan S.H., Yan S.F., and Schmidt A.M. Receptor for advanced glycation end products (RAGE) and the complications in diabetes. Aging Res Rev 1 (2002) 1-15
21. Lalla E., Lamster I.B., Feit M., et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 105 (2000) 1117-1124
22. Bucala R., Tracey K.J., and Cerami A. Advanced glycation end products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87 (1991) 432-438
23. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol Cell Physiol 271 (1996) C1424-C1437
24. Schmidt A.M., Yan S.D., Yan S.F., and Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108 (2001) 949-955
25. Wautier M.P., Chappey O., Corda S., Stern D.M., Schmidt A.M., and Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280 (2001) E685-E694
26. Basta G., Lazzerini G., Del Turco S., Ratto G.M., Schmidt A.M., and De Caterina R. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol 25 (2005) 1401-1407
27. Amore A., Cirina P., Mitola S., et al. Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int 51 (1997) 27-35
28. Rojas A., Caveda L., Romay C., et al. Effect of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages. Biochem Biophys Res Commun 225 (1996) 358-362
29. Sumi D., and Ignarro L.J. Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated RAW 264.7 cells. Diabetes 53 (2004) 1841-1850
30. Bierhaus A., Schiekofer S., Schwaninger M., et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-κB. Diabetes 50 (2001) 2792-2808